In ovarian cancer, it was shown that GBA expression is upregulated, and depletion with siRNA resulted in increased sensitivity to chemotherapy, as well as a reduction in signaling via the RTK Axl pathway [24]. The gene discussed is GBA1; the disease is ovarian cancer.